New Understanding of Enzyme’s Role in Prostate Cancer
Northwestern Medicine scientists have discovered that an enzyme called EZH2 can activate expression of the androgen receptor gene, which drives prostate cancer growth.
Browsing: "Cancer"
Inflammatory Bowel Disease Linked to Prostate Cancer
Men with inflammatory bowel disease have four to five times higher risk of prostate cancer, according to a new 20-year study.
New Regulator of Leukemia Discovered
Inhibiting CHAF1B, a protein that normally helps replenish blood cells, may be a promising treatment for leukemia, according to a recent study.
New Therapeutic Target Identified in Prostate Cancer
A Northwestern Medicine study has revealed new insights into a pathway in prostate cancer and identified a potential new therapeutic target for aggressive disease.
Chromosome Domain Inherits Information Without Using DNA Sequence
A recent study found that stability of chromatin structures across DNA replication requires cooperation between a histone chaperone and DNA replication machinery; a mechanism of epigenetic inheritance.
Cancer Crusader
Leon Platanias steers the Lurie Cancer Center toward better patient outcomes. Read the story in Northwestern Medicine magazine.
Fighting Cancer, Becoming an Adult
Teens and young adults with cancer get support from a special oncology program. Read the story in Northwestern Medicine magazine.
Critical Mass
Armed with a prestigious new grant, investigators prepare to rapidly translate scientific breakthroughs into better brain tumor therapies. Read the story in Northwestern Medicine magazine.
An Exceptional Cancer Center
The Lurie Cancer Center solidifies its place among the country’s elite after extraordinary growth and a top rating from the National Cancer Institute. Read the story in Northwestern Medicine magazine.
Epigenetics: Landscape of Disease
The Simpson Querrey Center for Epigenetics is connecting the Northwestern academic and medical community to integrate the study of epigenetics into science and clinical care.